Today: 9 April 2026
Subscribe
Browse Category

NYSE:KMB 23 January 2026 - 13 March 2026

Kenvue Stock Drops Today as Kimberly-Clark Selloff Cuts Takeover Offer Value

Kenvue Stock Drops Today as Kimberly-Clark Selloff Cuts Takeover Offer Value

Kenvue shares fell 1.6% to $17.39 late Thursday, trading just below the $17.81 value of Kimberly-Clark’s cash-and-stock takeover bid after a 2.2% drop in Kimberly-Clark shares. The gap reflects ongoing investor concerns over regulatory and litigation risks, including unresolved Tylenol lawsuits. Both companies’ shareholders approved the deal in January. The S&P 500 closed down 1.52% amid a broader market selloff.
13 March 2026
··
Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue exec stock grants land as Kimberly-Clark deal drags on

Kenvue awarded new restricted stock units to senior executives, including 127,051 units to North America head Carlos De Jesus and 122,286 to general counsel Matthew Orlando, according to SEC filings this week. The grants come as Kenvue awaits regulatory clearance for its $40 billion sale to Kimberly-Clark. Kenvue shares were up 0.3% at $18.25 in early U.S. trading Friday.
6 March 2026
···
Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble stock price ends Friday higher as tariff ruling sets up the week for PG shares

Procter & Gamble shares closed up 1.4% at $160.78 on Friday, outpacing both the S&P 500 and the consumer-staples sector. The move followed a Supreme Court ruling striking down Trump-era tariffs and new data showing U.S. GDP growth at 1.4% with core inflation at 2.7%. Investors have rotated into staples amid policy shifts and economic uncertainty. P&G last reported quarterly sales up 1% to $22.21 billion.
22 February 2026
····
Kenvue stock pops today: what KVUE investors are watching into earnings and the Kimberly-Clark deal

Kenvue stock pops today: what KVUE investors are watching into earnings and the Kimberly-Clark deal

Kenvue shares rose 1.8% to $18.50 Tuesday, tracking gains in Kimberly-Clark after shareholders approved a cash-and-stock takeover valuing Kenvue at about $19.10 per share. Kenvue’s dividend record date is Feb. 11, with quarterly results due Feb. 17. The deal is expected to close in the second half of 2026, pending regulatory approval.
10 February 2026
···
Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue stock price today: KVUE holds near $18 as Feb. 17 results and Kimberly-Clark deal hang over the week

Kenvue shares traded flat in premarket Tuesday, holding at $18.18 after Monday’s close. The company will report fourth-quarter and full-year results on Feb. 17 with no earnings call, citing its pending merger with Kimberly-Clark. Shareholders of record Feb. 11 will receive a $0.2075 dividend. The merger, approved Jan. 29, is expected to close in the second half of 2026, pending regulatory review.
10 February 2026
··
Kenvue (KVUE) stock price holds near $18 after hours as Feb. 17 results, deal timeline come into focus

Kenvue (KVUE) stock price holds near $18 after hours as Feb. 17 results, deal timeline come into focus

Kenvue shares rose 0.2% to $18.18 in after-hours trading Monday ahead of its Feb. 17 earnings release, which will not include a conference call due to its pending merger with Kimberly-Clark. Shareholders approved the deal Jan. 29, but closing is expected in the second half of 2026, pending approvals. ISS flagged ongoing litigation and regulatory scrutiny as risks. Volume reached about 91.5 million shares.
10 February 2026
··
P&G stock slides while Wall Street rises — what investors are watching this week

P&G stock slides while Wall Street rises — what investors are watching this week

Procter & Gamble shares fell 1.2% to $157.24 in Monday afternoon trading, underperforming the broader market as consumer-staples stocks weakened. Investors are awaiting U.S. jobs and inflation data due later this week. P&G’s last update showed flat sales and profit, with volume declines in key segments. The company declared a quarterly dividend of $1.0568 per share, payable Feb. 17.
9 February 2026
···
Kenvue stock price nudges higher premarket as traders watch Kimberly-Clark deal spread, dividend and Feb. 17 results

Kenvue stock price nudges higher premarket as traders watch Kimberly-Clark deal spread, dividend and Feb. 17 results

Kenvue shares rose 0.4% to $18.13 in premarket trading Monday, still about $1 below the value implied by Kimberly-Clark’s cash-and-stock offer. The dividend record date is Feb. 11, with earnings due Feb. 17. The deal awaits U.S. antitrust clearance and other approvals, with an outside date set for Nov. 2, 2026.
9 February 2026
····
Kenvue stock price holds near $18 as KVUE heads into a dividend date and Feb. 17 results

Kenvue stock price holds near $18 as KVUE heads into a dividend date and Feb. 17 results

Kenvue shares closed at $18.13 on Friday, about $1 below the implied $19.15 value of Kimberly-Clark’s pending cash-and-stock takeover. Shareholders of both companies overwhelmingly approved the deal, which is expected to close in the second half of 2026 pending regulatory review. Kenvue will report earnings on Feb. 17 without a conference call. The board declared a $0.2075 dividend, payable Feb. 25.
8 February 2026
···
Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue stock price holds near $18 as Kimberly-Clark deal math tightens — what to watch next week

Kenvue shares closed Friday at $18.13, up 0.33%, with about 63.5 million shares traded. The Kimberly-Clark offer values Kenvue at roughly $18.76 per share, leaving a deal spread of about 3%. Both companies’ shareholders approved the merger, which is expected to close in the second half of 2026 pending regulatory approvals. Kenvue’s dividend record date is Feb. 11, with earnings due Feb. 17.
7 February 2026
··
Kenvue stock price today: KVUE inches up as Feb. 17 results near and Kimberly-Clark deal math grips shares

Kenvue stock price today: KVUE inches up as Feb. 17 results near and Kimberly-Clark deal math grips shares

Kenvue shares rose 0.2% to $18.11 Friday afternoon, trading about 3.6% below Kimberly-Clark’s $18.79-per-share offer. Kenvue will report Q4 and full-year results on Feb. 17 but will skip its usual conference call as the merger process continues. Shareholders of both companies approved the deal on Jan. 29; regulatory clearance remains pending.
6 February 2026
···
Kenvue stock price today: KVUE ticks up premarket as Feb. 17 results near, earnings call scrapped

Kenvue stock price today: KVUE ticks up premarket as Feb. 17 results near, earnings call scrapped

Kenvue shares rose 0.2% premarket Friday after the company set Feb. 17 for its earnings release and said it will not hold a quarterly call due to its pending deal with Kimberly-Clark. Each Kenvue share will convert into 0.14625 Kimberly-Clark shares plus $3.50 cash if the merger closes, leaving Kenvue stock about 70 cents below the implied value. Investors remain focused on deal timing and ongoing product litigation.
6 February 2026
···
Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
30 January 2026
····
Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue stock price dips as KVUE dividend set and Kimberly-Clark vote nears

Kenvue shares fell 0.3% to $17.44 Wednesday as investors awaited a Jan. 29 shareholder vote on Kimberly-Clark’s takeover bid. Kenvue declared a $0.2075 quarterly dividend, payable Feb. 25. The merger would give Kenvue holders 0.14625 Kimberly-Clark shares plus $3.50 cash per share. Kenvue and its board face shareholder lawsuits seeking more merger disclosures.
28 January 2026
···
Kenvue stock edges higher as Kimberly-Clark profit beat puts takeover vote back in play

Kenvue stock edges higher as Kimberly-Clark profit beat puts takeover vote back in play

Kenvue shares rose 0.2% after Kimberly-Clark reported strong quarterly results and reaffirmed its $40 billion bid. Shareholders vote on the deal Jan. 29, with Kenvue holders set to receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Both companies confirmed financing plans. Deal risk persists due to Kenvue’s ongoing lawsuits and regulatory scrutiny.
27 January 2026
··
Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week

Kenvue stock steadies near $18 as investors eye Jan. 29 merger vote — here’s what matters next week

Kenvue closed Friday at $17.80, up 0.3%, ahead of a merger vote with Kimberly-Clark set for Jan. 29. The deal values Kenvue shares at about $18.45, but ongoing shareholder lawsuits and unresolved litigation over Kenvue brands threaten delays. Proxy advisers back the deal despite legal risks. Both companies hold shareholder meetings Monday to decide the merger’s fate.
25 January 2026
··
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.
23 January 2026
···
1 2 3

Stock Market Today

  • QuidelOrtho (QDEL) Shares Slide 23% in a Month Amid Valuation Debate
    April 8, 2026, 9:37 PM EDT. QuidelOrtho (QDEL) shares slipped 22.86% over the past month to $15.32, despite a 2.27% gain on the latest trading day. The stock's 1-year total shareholder return tallies 46.90%, showing past momentum is fading. Analysts flag a sharp valuation gap: market price trails the $34.67 fair value estimate by over 80%, spotlighting risks in execution and reimbursement trends. Expansion into global markets like Latin America and Asia Pacific offers growth potential, underpinned by demand for early detection and immunoassay technologies. But COVID testing normalization and product discontinuations weigh on revenue diversity and margins. Investors should weigh these mixed signals carefully and consider broadening healthcare AI exposure rather than concentrating on one stock story.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Go toTop